Genor Biopharma targets $371m from Hong Kong IPO

Jonathan Breen

September 23, 2020 06:45 am

JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Macquarie Group JP Morgan Equity IPOs Health and Biotech Equity China Merchants Bank Co China Jefferies LLC Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets SRI Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia